Syndicate This week's upcoming IPO's and secondary offerings

Week of January 27 to January 31, 2024

This Day's Priced Deals: January 29th, 2020

Symbol

Issuer

Type

Price

Managers

ANVS

Annovis Bio
Annovis Bio
IPO
Priced: $6.00
2M
ThinkEquity

Pricing after close
Deal analysis and details

Managers: ThinkEquity

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BHVN

Biohaven Pharmaceutical
Biohaven Pharmaceutical
Secondary
Priced: $51.75
4.831M
Goldman Sachs

Pricing after close

Managers: Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DNLI

Denali Therapeutics
Denali Therapeutics
Secondary
Priced: $23.00
7.83M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, JPMorgan & Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AVGR

Avinger
Avinger
Spot Secondary
Priced: $0.70
6.43M
Aegis

Pricing after close

Managers: Aegis

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CERS

Cerus
Cerus
Spot Secondary
Priced: $3.88
14.178M
BTIG

Pricing after close
Deal analysis and details

Managers: BTIG

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Deals to be Priced

01/30 - Thursday

Symbol

Issuer

Type

Price

Managers

AHI

Avadim Health
Avadim Health
IPO
$14.00-16.00
5M
Raymond James & Truist,...

Pricing after close
Deal analysis and details

Managers: Raymond James & Truist, Oppenheimer, Maxim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

01/27 - Monday

Symbol

Issuer

Type

Price

Managers

CNCE

Concert Pharmaceuticals
Concert Pharmaceuticals
Spot Secondary
Priced: $9.92
4.75M
Jefferies

Pricing after close

Managers: Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

01/28 - Tuesday

Symbol

Issuer

Type

Price

Managers

ANVS

Annovis Bio
Annovis Bio
IPO
Priced: $6.00
2M
ThinkEquity

Pricing after close
Deal analysis and details

Managers: ThinkEquity

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BHVN

Biohaven Pharmaceutical
Biohaven Pharmaceutical
Secondary
Priced: $51.75
4.831M
Goldman Sachs

Pricing after close

Managers: Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DNLI

Denali Therapeutics
Denali Therapeutics
Secondary
Priced: $23.00
7.83M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, JPMorgan & Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AVGR

Avinger
Avinger
Spot Secondary
Priced: $0.70
6.43M
Aegis

Pricing after close

Managers: Aegis

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CERS

Cerus
Cerus
Spot Secondary
Priced: $3.88
14.178M
BTIG

Pricing after close
Deal analysis and details

Managers: BTIG

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

01/29 - Wednesday

Symbol

Issuer

Type

Price

Managers

BDTX

Black Diamond Therapeutics
Black Diamond Therapeutics
IPO
Priced: $19.00
10.59M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Jefferies & TD Cowen, Canaccord

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ALEC

Alector
Alector
Secondary
Priced: $25.00
8.35M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley, Goldman Sachs, BofA & TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DBVT

DBV Technologies
DBV Technologies
Secondary
Priced: $10.25
9.071M
Goldman Sachs & Citi,...

Pricing after close

Managers: Goldman Sachs & Citi, JMP Securities, H.C. Wainwright, Kempen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ESTA

Establishment Labs
Establishment Labs
Secondary
Priced: $26.25
22.86M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Jefferies & UBS, PJT Partners

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GO

Grocery Outlet
Grocery Outlet
Secondary
Priced: $33.00
16M
BofA

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ALBO

Albireo Pharma
Albireo Pharma
Spot Secondary
Priced: $21.00
1.905M
Jefferies

Pricing after close
Deal analysis and details

Managers: Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

01/30 - Thursday

Symbol

Issuer

Type

Price

Managers

ANPC

AnPac Bio
AnPac Bio
IPO
Priced: $12.00
1.33M
WestPark Capital & Univest

Intra-day pricing

Managers: WestPark Capital & Univest

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ARQT

Arcutis Biotherapeutics
Arcutis Biotherapeutics
IPO
Priced: $17.00
9.375M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, TD Cowen & Guggenheim, Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ONEM

1Life Healthcare
1Life Healthcare
IPO
Priced: $14.00
17.5M
JPMorgan & Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: JPMorgan & Morgan Stanley, Allen & Co., Citi, Piper Sandler, Wells Fargo, William Blair, Baird, Truist

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
REYN

Reynolds Consumer Products
Reynolds Consumer Products
IPO
Priced: $26.00
47.17M
Credit Suisse,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Credit Suisse, Goldman Sachs & JPMorgan, Barclays, Citi, Evercore ISI, RBC Capital, HSBC, Stifel, Truist, Acadamy Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CATB

Catabasis Pharmaceuticals
Catabasis Pharmaceuticals
Secondary
Priced: $5.00
4.6M
Oppenheimer

Pre-open pricing
Deal analysis and details

Managers: Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ITMR

Itamar Medical
Itamar Medical
Secondary
Priced: $13.75
2.545M
Piper Sandler

Pricing after close
Deal analysis and details

Managers: Piper Sandler

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NEPH

Nephros
Nephros
Secondary
Priced: $8.00
937500
Craig-Hallum

Pricing after close

Managers: Craig-Hallum

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
POL

PolyOne
PolyOne
Secondary
Priced: $33.75
13.33M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, Citi & Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KZR

Kezar Life Sciences
Kezar Life Sciences
Spot Secondary
Priced: $2.60
16.115M
TD Cowen,...

Pricing after close
Deal analysis and details

Managers: TD Cowen, Wells Fargo & William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NTEC

Intec Pharma
Intec Pharma
Spot Secondary
Priced: $.40
16.25M
H.C. Wainwright

Pricing after close

Managers: H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access